New Technology Detects Cervical Lesions

FEBRUARY 01, 2005

A review of 3 earlier studies found that using speculoscopy—bright light technology—immediately following a Pap smear may help physicians discover more cervical cancer lesions than the Pap test alone. A negative, however, is that the combination approach may also up the risk of false positives. Analyses of the studies found that using speculoscopy together with Pap smear detected an additional 42 to 62 lesions per 1000 patients screened. The evidence also showed an increase in the number of false positives from 55 to 111 per 1000 patients screened. The reviewers noted, that, because the review found only 3 studies that compared Pap smear alone with Pap smear and speculoscopy, the current data regarding the technology is not strong.



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.